SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-23-008874
Filing Date
2023-01-31
Accepted
2023-01-31 21:51:39
Documents
2
Period of Report
2023-01-29

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm235103-2_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm235103-2_4seq1.xml 4 11985
2 EXHIBIT 24 tm235103d2_ex24.htm EX-24 6206
  Complete submission text file 0001104659-23-008874.txt   19594
Mailing Address ONYX PHARMACEUTICALS, INC. 249 E. GRAND AVE. SOUTH SAN FRANCISCO CA 94080
Business Address
CAGNONI PABLO J (Reporting) CIK: 0001205703 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38586 | Film No.: 23574574

Mailing Address 399 BINNEY STREET, SUITE 300 CAMBRIDGE MA 02139
Business Address 399 BINNEY STREET, SUITE 300 CAMBRIDGE MA 02139 617-679-9600
Rubius Therapeutics, Inc. (Issuer) CIK: 0001709401 (see all company filings)

IRS No.: 042688109 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)